Qualitest confirms launch of generic Singulair Tablets for asthma and allergic rhinitis

Download PDF Copy

Aug 6 2012

NewsGuard 100/100 Score

Qualitest Pharmaceuticals today confirmed that it has launched a generic version of Singulair (montelukast sodium) Tablets and Chewable Tablets, following the expiration of the last patent that provides Merck U.S. market exclusivity. Qualitest will begin shipping the product immediately. Montelukast Sodium Tablets are labeled for use in treating symptoms of asthma and allergic rhinitis.

The total combined sales for Montelukast Sodium Tablets and Chewables in the U.S. for the 12 months ending June 30, 2012, were approximately $4.9 billion, according to IMS Health.

Source:

Qualitest Pharmaceuticals

Posted in: Medical Condition News | Medical Patent News | Pharmaceutical News

Tags: Allergic Rhinitis, Allergy, Asthma, Endocrinology, Oncology, Pain, Pharmaceuticals, Rhinitis, Urology

Comments (0)

Download PDF Copy

Suggested Reading

Long-term air pollution exposure increases asthma risk in children and adults

Long-term air pollution exposure increases asthma risk in children and adults

Asthma associated with memory issues in children

Asthma associated with memory issues in children

Diabetes drugs cut asthma attacks by up to 70%, reshaping treatment options

Diabetes drugs cut asthma attacks by up to 70%, reshaping treatment options

New study confirms: Anti-inflammatory inhalers reduce severe asthma complications

New study confirms: Anti-inflammatory inhalers reduce severe asthma complications

Exposure to everyday chemicals during pregnancy may raise asthma risk in children

Exposure to everyday chemicals during pregnancy may raise asthma risk in children

Long-term PM2.5 exposure increases asthma risk

Long-term PM2.5 exposure increases asthma risk

Research uncovers how inhaled house dust mites trigger of allergic asthma

Research uncovers how inhaled house dust mites trigger of allergic asthma

Rare STAT6 gene variant provides protection against severe asthma

Rare STAT6 gene variant provides protection against severe asthma

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Researchers explore pathways linking infant antibiotic use to childhood asthma